US2017307592A1PendingUtilityA1
Neuroprotective Chemicals and Methods for Identifying and Using Same
Est. expiryNov 11, 2033(~7.3 yrs left)· nominal 20-yr term from priority
G01N 33/5058G01N 33/5038G01N 2333/91142G01N 33/5014C12Q 1/48A61K 38/00
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein are methods for identifying a compound having cell-protective (e.g., neuroprotective) activity. Compounds identified therefrom are also provided. These compounds can be used to treat various diseases, disorders, or conditions associated with, for example, unwanted cell death.
Claims
exact text as granted — not AI-modified1 . A method for identifying a compound having cell-protective activity, comprising:
incubating a test compound with a nicotinamide phosphoribosyltransferase (NAMPT); and measuring an activity of the NAMPT; wherein an increase in the activity of the NAMPT compared to a control that is not incubated with the test compound is indicative of cell-protective activity of the test compound.
2 . The method of claim 1 , wherein in the incubating step, the NAMPT is recombinantly produced.
3 . The method of claim 1 , wherein in the incubating step, the NAMPT is present at about 0.1 to about 10 μM, about 0.5 to about 5 μM, or about 1 μM.
4 . The method of claim 1 , further comprising incubating the test compound with nicotinamide, phosphoribosylpyrophosphate, alcohol dehydrogenase, nicotinamide mononucleotide adenylyl-transferase, and an alcohol.
5 . The method of claim 4 , wherein the alcohol is ethanol.
6 . The method of claim 1 , wherein the measuring step comprises determining an amount of nicotinamide adenine dinucleotide reduced form (NADH) and/or nicotinamide mononucleotide (NMN).
7 . The method of claim 6 , wherein the amount of NADH and/or NMN is measured by ultra violet light, mass spectrometry or fluorescence.
8 . The method of claim 7 , wherein the amount of NADH is measured by optical density 340 nm.
9 . The method of claim 6 , wherein an increase in the amount of NADH and/or NMN is indicative of increased NAMPT activity.
10 . The method of claim 1 , wherein the test compound having said cell-protective activity is determined to bind and/or activate the NAMPT.
11 . The method of claim 1 , wherein the cell-protective activity is neuroprotective activity which includes one or more of: promoting survival, health, integrity, growth, development and/or function of neurons, protecting neurons from cell death, apoptosis and/or degeneration, and/or stimulating neurogenesis.Join the waitlist — get patent alerts
Track US2017307592A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.